5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Mitral Stenosis
Mitral stenosis is a cardiac condition characterized by the narrowing of the mitral valve, the valve that separates the left atrium from the left ventricle in the heart. This constriction impedes the smooth flow of blood from the atrium to the ventricle, leading to various cardiovascular complications. Typically associated with rheumatic fever, a historical bacterial infection, mitral stenosis causes symptoms such as shortness of breath, fatigue, and palpitations. As the condition progresses, it can result in decreased cardiac output and increased pressure in the pulmonary veins. Timely diagnosis and intervention, often through medical management or surgical procedures like balloon valvuloplasty or valve replacement, are crucial in managing the impact of mitral stenosis on heart function and improving patients' quality of life.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain